NASDAQ:CRSP

Crispr Therapeutics Stock News

etoro logo Buy CRSP
*Your capital is at risk
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
These top seven stocks among Cathie Wood's top holdings are ones investors may be enticed to consider right now. The post 7 Cathie Wood Stocks Every Growth Investor Needs In Their Portfolio appeared f
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $117.81, moving +0.48% from the previous trading session.

Is Now the Time to Ditch Pharma Stocks?

06:45am, Tuesday, 21'st Sep 2021
With drug pricing reform on the horizon, investors may want to analyze their allocation.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
They're leaders in therapeutic areas with massive growth potential.

7 Gene Editing Stocks Promising to Change our DNA

12:45pm, Wednesday, 15'th Sep 2021
Gene editing stocks will take off as the underlying tech moves from fiction to fact and companies put their products on the market. The post 7 Gene Editing Stocks Promising to Change our DNA appeared
Cathie Wood and her funds are generating a lot of interest among investors for smart picks, and these Cathie Wood stocks are worth a look. The post 7 Cathie Wood Stock Favorites to Keep on Your Radar
As the saying goes, bulls and bears make money. And today in these three Cathie Wood stocks both camps should be ready for action The post 3 Cathie Wood Stocks To Trade for Bulls as Well as Bears appe
A crowded field could take years to thin out.
CRISPR Therapeutics' clinical programs are progressing nicely, showing excellent safety and efficacy, validating the prospects of its novel technology as a disruptive force in the biotech industry. Di
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
The stock price of CRISPR Therapeutics, a biotechnology gene editing company focused on developing gene-based medicines for human diseases, reached an all-time high of $210 in January of this year bef
Looking for a terrific value in the biotechnology space? It doesn't get much better than CRSP stock, which just entered a buy zone.

How Are Genomics ETFs Responding to Q2 Earnings?

10:00am, Saturday, 14'th Aug 2021
Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.
The stock dropped roughly $40 per share over the course of the month.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE